Compare Eli Lilly And Co (LLY) vs Modine Manufacturing Company (MOD) Price & Performance

Eli Lilly (LLY) trades at $1,176.69, down 1.01% on the day, amid a bullish technical outlook and strong fundamental performance. The stock has consistently beaten earnings estimates, with Q2 2026 EPS of $8.38 surpassing the $6.40 consensus. Revenue surged to $65.18B in 2025, driving a net income margin of 33.53%. Recent news highlights promising pipeline developments in weight-loss and diabetes drugs, reinforcing growth prospects.

The outlook remains positive given robust revenue growth, high profitability, and analyst consensus favoring buys. Key risks include elevated valuation multiples and competitive pressures in the pharmaceutical sector. With a consensus price target of $1,350, upside potential exists, but investors should weigh execution risks against the company's innovation pipeline.

Modine Manufacturing (MOD) trades at $184.32, down 2.7% on the day, amid a recent spin-off of its Performance Technologies unit. The stock exhibits bearish technical signals with support at $177 and resistance at $187. Fundamentally, the company reported strong Q2 2026 earnings of $1.53 per share, beating estimates, but faces margin compression with net income margin declining from 7.12% in 2025 to 4.27% in 2026. Analyst sentiment remains positive with a consensus price target of $331.25 and 10 buy ratings.

The outlook for MOD is mixed; the spin-off could streamline operations and focus on thermal management growth, but integration risks and margin pressures pose challenges. The stock trades at a high P/E of 67.87, suggesting premium valuation. Upside depends on execution of the new corporate strategy and data center cooling expansion, while downside risks include competitive pressures and macroeconomic headwinds affecting industrial demand.